Need Help?

NSCLC Whole Genome Sequencing data

There are 64 NSCLC samples, including pre-treatment, post-treatment, and normal samples, sequenced by whole genome sequencing technology and archived in bam files.

Request Access

NSCLC Data Access Policy

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom Pier Selenica grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: Pier Selenica and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. Pier Selenica: Memorial Sloan Kettering Cancer Center 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify Pier Selenica within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify Pier Selenica prior to any significant changes to the protocol for the Project. 14. The User Institution will notify Pier Selenica as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. Pier Selenica may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than Pier Selenica. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of England and Wales and shall be subject to the exclusive jurisdiction of the English courts.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001005526 Whole Genome Sequencing

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00005420397 bam 143.5 GB
EGAF00005420398 bam 143.1 GB
EGAF00005420399 bam 145.8 GB
EGAF00005420400 bam 146.0 GB
EGAF00005420401 bam 266.5 GB
EGAF00005420402 bam 270.8 GB
EGAF00005420403 bam 153.3 GB
EGAF00005420404 bam 150.4 GB
EGAF00005420405 bam 138.0 GB
EGAF00005420406 bam 146.4 GB
EGAF00005420407 bam 155.8 GB
EGAF00005420408 bam 143.0 GB
EGAF00005420409 bam 288.3 GB
EGAF00005420410 bam 140.5 GB
EGAF00005420411 bam 141.4 GB
EGAF00005420412 bam 147.8 GB
EGAF00005420413 bam 272.7 GB
EGAF00005420414 bam 145.0 GB
EGAF00005420415 bam 151.0 GB
EGAF00005420416 bam 137.7 GB
EGAF00005420417 bam 145.5 GB
EGAF00005420418 bam 152.6 GB
EGAF00005420419 bam 275.9 GB
EGAF00005420420 bam 138.4 GB
EGAF00005420421 bam 138.3 GB
EGAF00005420422 bam 143.4 GB
EGAF00005420423 bam 140.2 GB
EGAF00005420424 bam 142.8 GB
EGAF00005420425 bam 288.6 GB
EGAF00005420426 bam 138.7 GB
EGAF00005420427 bam 266.3 GB
EGAF00005420428 bam 283.9 GB
EGAF00005420429 bam 149.4 GB
EGAF00005420430 bam 144.2 GB
EGAF00005433041 bam 287.2 GB
EGAF00005433042 bam 270.2 GB
EGAF00005433043 bam 315.1 GB
EGAF00005433044 bam 276.1 GB
EGAF00005433045 bam 283.0 GB
EGAF00005433046 bam 277.8 GB
EGAF00005433047 bam 284.5 GB
EGAF00005433048 bam 276.9 GB
EGAF00005433049 bam 312.4 GB
EGAF00005433050 bam 325.8 GB
EGAF00005433051 bam 297.0 GB
EGAF00005433052 bam 287.7 GB
EGAF00005433053 bam 274.8 GB
EGAF00005433054 bam 254.4 GB
EGAF00005433055 bam 271.7 GB
EGAF00005433056 bam 265.7 GB
EGAF00005433057 bam 256.1 GB
EGAF00005433058 bam 273.1 GB
EGAF00005433059 bam 254.8 GB
EGAF00005433060 bam 285.6 GB
EGAF00005433061 bam 322.8 GB
EGAF00005433062 bam 295.6 GB
EGAF00005433063 bam 327.2 GB
EGAF00005433064 bam 265.3 GB
EGAF00005433065 bam 318.6 GB
EGAF00005433066 bam 338.6 GB
EGAF00005433067 bam 352.3 GB
EGAF00005433068 bam 314.9 GB
EGAF00005433069 bam 324.1 GB
EGAF00005433070 bam 385.4 GB
64 Files (14.8 TB)